Celltrion USA, Inc. announced that it expects to receive $532.1 million in funding from Celltrion, Inc.

Celltrion USA, Inc. announced that it will issue 100 common shares at a price of $5,321,000 per share for gross proceeds of $532,100,000 on December 11, 2025. The transaction include the participation from new investor Celltrion, Inc. The company will issue the shares through Participation in paid-in capital increase through shareholder allocation method. The transaction is expected to close on December 18, 2025.

The company will receive two tranches in the transaction of $445,800,000 on December 18, 2025 and $86,300,000 in 2026.